Healthcare Economist December 17, 2025
In my latest Guest Column in The Evidence Base, II am joined by my colleague Tiago Beck as we examine how global pricing reforms are reshaping the European pharmaceutical landscape.
Building on their session at ISPOR Europe 2025, the column explores the growing tension between EU access ambitions and international policy pressures – offering a timely perspective in light of last week’s agreement on the EU pharma package. An excerpt is below.
The European Union finds itself in an unprecedented policy paradox. It has just concluded negotiations on its landmark pharmaceutical reform – formally known as the EU General Pharmaceutical Legislation and commonly...
Today's Sponsors
Today's Sponsor